Thiogenesis Therapeutics, Corp.

TSXV:TTI Stock Report

Market Cap: CA$27.3m

Thiogenesis Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Patrice Rioux

Chief executive officer

CA$261.7k

Total compensation

CEO salary percentage100.0%
CEO tenure2.7yrs
CEO ownership14.9%
Management average tenureno data
Board average tenure2.7yrs

Recent management updates

Recent updates

We Think Thiogenesis Therapeutics (CVE:TTI) Needs To Drive Business Growth Carefully

Jul 17
We Think Thiogenesis Therapeutics (CVE:TTI) Needs To Drive Business Growth Carefully

Here's Why We're Not Too Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Situation

Aug 25
Here's Why We're Not Too Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Situation

We're Not Very Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Rate

May 01
We're Not Very Worried About Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Rate

CEO Compensation Analysis

How has Patrice Rioux's remuneration changed compared to Thiogenesis Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CA$4m

Mar 31 2024n/an/a

-CA$5m

Dec 31 2023CA$262kCA$262k

-CA$5m

Sep 30 2023n/an/a

-CA$3m

Jun 30 2023n/an/a

-CA$3m

Mar 31 2023n/an/a

-CA$3m

Dec 31 2022CA$139kCA$139k

-CA$4m

Compensation vs Market: Patrice's total compensation ($USD187.74K) is about average for companies of similar size in the Canadian market ($USD173.45K).

Compensation vs Earnings: Patrice's compensation has increased whilst the company is unprofitable.

CEO

Patrice Rioux (73 yo)

2.7yrs

Tenure

CA$261,683

Compensation

Dr. Patrice P. Rioux, M. D., Ph. D, is a Co-founder of Thiogenesis Therapeutics, Corp. and its Chief Executive Officer and Director since March 31, 2022. He serves as Co-President, Director and Chief Execu...

Board Members

NamePositionTenureCompensationOwnership
Patrice Rioux
Co-Founder2.7yrsCA$261.68k14.88%
CA$ 4.1m
Brook G. Riggins
CFO, Secretary & Director6.5yrsCA$221.78k2.31%
CA$ 630.0k
Christopher Starr
Independent Chairman2.7yrsCA$32.39kno data
David Housman
Member of Scientific Advisory Board2.3yrsno datano data
Kim Tsuchimoto
Independent Director2.7yrsCA$32.39kno data
Miriam Vos
Member of Scientific Advisory Board2.3yrsno datano data
W. Mullally
Independent Director6.5yrsCA$32.21k1.92%
CA$ 525.0k
Gregory Enns
Member of Scientific Advisory Board2.3yrsno datano data

2.7yrs

Average Tenure

66.5yo

Average Age

Experienced Board: TTI's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.